BRIEF-Vexim says Anvisa approves Spinejack implants in Brazil
* HAS RECEIVED REGULATORY APPROVAL FROM ANVISA(1), BRAZIL'S NATIONAL HEALTH SURVEILLANCE AGENCY, IN ORDER TO COMMERCIALIZE SPINEJACK® IN BRAZIL.
Dec 15 Boryung Pharm Co Ltd :
* Says it will issue 0.05 bonus shares for every one share to shareholders
* Says total amount of bonus shares is 410,000
* Says the listing date is Jan. 26, 2017
Source text in Korean: goo.gl/17VWxD
Further company coverage:
(Beijing Headline News)
SAO PAULO, May 29 Brazilian healthcare services provider Notre Dame Intermédica Sistema de Saúde SA on Monday filed for regulatory clearance to launch an initial public offering, the latest in a wave of stock listings in Latin America's largest economy after a years-long drought.